Employees Retirement System of Texas’s Jazz Pharmaceuticals JAZZ Stock Holding History

Employees Retirement System of Texas’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-22,780	Closed	-$2.54M	–	344
2024 Q3	$2.54M	Hold	22,780	–	–	0.02%	235
2024 Q2	$2.43M	Hold	22,780	–	–	0.02%	210
2024 Q1	$2.74M	Sell	22,780 -15,000	-40%	-$1.84M	0.03%	212
2023 Q4	$4.65M	Hold	37,780	–	–	0.05%	176
2023 Q3	$4.89M	Hold	37,780	–	–	0.07%	144
2023 Q2	$4.68M	Sell	37,780 -8,600	-19%	-$1.16M	0.06%	162
2023 Q1	$6.79M	Sell	46,380 -6,530	-12%	-$966K	0.1%	151
2022 Q4	$8.43M	Hold	52,910	–	–	0.12%	176
2022 Q3	$7.05M	Hold	52,910	–	–	0.11%	202
2022 Q2	$8.25M	Hold	52,910	–	–	0.12%	209
2022 Q1	$8.24M	Hold	52,910	–	–	0.1%	240
2021 Q4	$6.74M	Sell	52,910 -6,590	-11%	-$866K	0.08%	274
2021 Q3	$7.75M	Buy	59,500 +10,910	+22%	+$1.65M	0.09%	257
2021 Q2	$8.63M	Buy	48,590 +42,000	+637%	+$7.28M	0.11%	231
2021 Q1	$1.08M	Hold	6,590	–	–	0.01%	662
2020 Q4	$1.09M	Hold	6,590	–	–	0.02%	579
2020 Q3	$940K	Hold	6,590	–	–	0.01%	642
2020 Q2	$727K	Hold	6,590	–	–	0.01%	670
2020 Q1	$657K	Hold	6,590	–	–	0.01%	655
2019 Q4	$984K	Hold	6,590	–	–	0.02%	704
2019 Q3	$844K	Buy	+6,590	New	+$883K	0.01%	750

Other funds holding JAZZ

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Employees Retirement System of Texas's JAZZ Position: Q4 2024 in Review

Employees Retirement System of Texas sold out of Jazz Pharmaceuticals (JAZZ) in Q4 2024, closing a stake of 22,780 shares — an estimated $2.54M sold.

Employees Retirement System of Texas first reported a position in JAZZ in Q3 2019 and held it in 21 quarters. The position peaked at $8.63M in Q2 2021. 508 funds tracked by Wall St. Rank hold JAZZ as of Q4 2024.

Employees Retirement System of Texas reported no remaining Jazz Pharmaceuticals position as of Q4 2024 after selling out during the quarter.
Employees Retirement System of Texas sold 22,780 Jazz Pharmaceuticals shares in Q4 2024, an estimated $2.54M.
Employees Retirement System of Texas first reported a position in Jazz Pharmaceuticals in Q3 2019 and held it in 21 quarters.
Employees Retirement System of Texas's Jazz Pharmaceuticals position peaked at $8.63M in Q2 2021.
508 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q4 2024.

Based on Employees Retirement System of Texas's 13F filing for Q4 2024, filed 13 Feb 2025.